CN107281328A - One kind treats dermopathic herbal composite and its manufacture method - Google Patents
One kind treats dermopathic herbal composite and its manufacture method Download PDFInfo
- Publication number
- CN107281328A CN107281328A CN201710425583.6A CN201710425583A CN107281328A CN 107281328 A CN107281328 A CN 107281328A CN 201710425583 A CN201710425583 A CN 201710425583A CN 107281328 A CN107281328 A CN 107281328A
- Authority
- CN
- China
- Prior art keywords
- parts
- herbal composite
- pigeonpea
- manufacture method
- dermopathic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides one kind and treats dermopathic herbal composite and its manufacture method, and wherein herbal composite is made up of following parts by weight raw material：35 parts of picria fel tarrae, 6 10 parts of pigeonpea, 6 10 parts of frutus cnidii, 25 parts of rose glorybower root, 10 15 parts of Celastrus angulatus, 10 15 parts of Chinese alangium leaf.Said composition further comprises the ethanol used in the fabrication process, AEO, alkylglycoside, dodecyl benzyl dimethyl ammonium chloride, OIT.The composition being made is having good effect to treating for skin disease, to no skin irritation.
Description
Technical field
The present invention relates to field of traditional Chinese medicine technology, more particularly to one kind treats dermopathic herbal composite and its system
Make method.
Background technology
Skin disease be skin (including hair and first) by after the influence of internal and external factor, its form, 26S Proteasome Structure and Function are sent out
Changing, produces pathologic process.The dermopathic incidence of disease is high, and most of illnesss are light, not unhealthful.But minority is heavier or even can
With threat to life.
At present, treat above-mentioned skin disease and be broadly divided into western medical treatment and Chinese traditional treatment.Treating skin disease is typically adopted at present
With the external application of ointment of Western medicine, effect is general.Doctor trained in Western medicine is more with calm, stable, hypnosis and antihistamine, hormone medicine, or using general
Shandong cacaine vein closing or calcium agent intravenous injection, not only effect is not good, and side effect is big, is often accompanied by allergic etc. bad anti-
Should, injected organism tissue and skin injury, and easily recurrence are easily caused, patient is more, and bitter its tires out.The traditional Chinese medical science is then more with dispelling wind dampness removing, clearly
It is heat, dampness removing, antipruritic；Or clearing liver-fire, nourishing the blood to expel wind is moisturized, for the purpose of enriching the blood to restore normal menstruation, though it is with strong points, it is small using scope,
With larger limitation, easily recurrence.
The content of the invention
Dermopathic herbal composite and manufacture method are treated it is an object of the present invention to provide one kind, therapeutic effect is good, with
Solve the undesirable effect that currently used doctor trained in Western medicine technology treatment is produced.
The present invention treats dermopathic herbal composite by providing one kind, and it includes the raw material of following parts by weight：
3-5 parts of picria fel tarrae, 6-10 parts of pigeonpea, 6-10 parts of frutus cnidii, 2-5 parts of rose glorybower root, 10-15 parts of Celastrus angulatus, Chinese alangium leaf 10-15
Part.
The above-mentioned dermopathic herbal composite for the treatment of, including following parts by weight raw material：5 parts of picria fel tarrae, 10 parts of pigeonpea,
7 parts of frutus cnidii, 3 parts of rose glorybower root, 15 parts of Celastrus angulatus, 15 parts of Chinese alangium leaf.
The preparation method of the herbal composite is：Total medicinal material is obtained after ethanol solution second extraction concentration Chinese herbal medicine to contain
Amount 8% medicinal extract, by 1kg AEOs, 1.5kg alkylglycosides, 0.5kg dodecyl benzyl dimethyl ammonium chlorides,
2kg OITs are dissolved in 10kg deionized water, add the medicinal extract that 8kg is concentrated to give.Mixture heating stirring 4hr,
20 DEG C of elimination insoluble matters are cooled to get product.
The formula of the present invention has the following effects that：
Picria fel tarrae, clearing heat and detoxicating, swelling and pain relieving.
Pigeonpea, clearing heat and detoxicating, tonifying middle-Jiao and Qi, inducing diuresis and reducing edema, blood stasis removing analgesic, blood stasis and swelling pain.
Frutus cnidii, warming kidney and enhancing yang, dispelling wind and arresting itching.
Rose glorybower root, invigorating the spleen tonifying Qi, promoting blood circulation, subdhing swelling and detoxicating, dizzy for controlling uterine bleeding, void is coughed, hypertension, rheumatalgia.
Celastrus angulatus, heat-clearing and damp-drying drug, detoxify desinsection.
Chinese alangium leaf, stagnation resolvation synthetism effect.
AEO, is with relatively low excitant and biology with wetting, emulsification, hard water resistance characteristic
The nonionic surfactant of degradation function.
Alkylglycoside, it is weak to skin irritation, with broad spectrum antibiotic activity.
Dodecyl benzyl dimethyl ammonium chloride, the sterilization algae removal ability with broad-spectrum high efficacy.
OIT, a kind of wide spectrum, efficient, low toxicity, non-oxidative bactericide.
The dermopathic herbal composite raw material for the treatment of that the present invention is provided is natural Chinese medicinal herb, and human skin is acted on
Gently, with preferable therapeutic effect.The compound added in the processing procedure of Chinese herbal medicine can increase finished product curative effect and
Store duration.The present invention can solve the present situation that western medicines in treatment limitation of the prior art is big, therapeutic effect is not good.
Embodiment
This specification will be further illustrated by following examples.
Embodiment 1
One kind treats dermopathic herbal composite, including following parts by weight raw material：3 parts of picria fel tarrae, 7 parts of pigeonpea,
7 parts of frutus cnidii, 3 parts of rose glorybower root, 10 parts of Celastrus angulatus, 10 parts of Chinese alangium leaf.
Embodiment 2
One kind treats dermopathic herbal composite, including following parts by weight raw material：4 parts of picria fel tarrae, 7 parts of pigeonpea,
8 parts of frutus cnidii.
Embodiment 3
One kind treats dermopathic herbal composite, including following parts by weight raw material：3 parts of picria fel tarrae, 9 parts of pigeonpea,
6 parts of frutus cnidii, 4 parts of rose glorybower root, 13 parts of Celastrus angulatus, 15 parts of Chinese alangium leaf.
Embodiment 4
One kind treats dermopathic herbal composite, including following parts by weight raw material：4 parts of picria fel tarrae, 8 parts of pigeonpea,
6 parts of frutus cnidii, 3 parts of rose glorybower root, 12 parts of Celastrus angulatus, 14 parts of Chinese alangium leaf.
Embodiment 5
One kind treats dermopathic herbal composite, including following parts by weight raw material：5 parts of picria fel tarrae, 9 parts of pigeonpea,
6 parts of frutus cnidii.
Embodiment 6
One kind treats dermopathic herbal composite, including following parts by weight raw material：4 parts of picria fel tarrae, 8 parts of pigeonpea,
6 parts of frutus cnidii, 3 parts of rose glorybower root, 10 parts of Celastrus angulatus, 15 parts of Chinese alangium leaf.
Clinical test
Experimental group：Using the herbal composite product of embodiment 1 through manufacturing obtained medicament, using external application affected part
Mode, it is continuous to use 14 days daily using twice.
Control group 1：The medicament of skin disease containing plant component sold using pharmacy, is smeared affected part, continuously used twice daily
21 days.
Control group 2：The antifungal activity skin disease medicament sold using pharmacy, is smeared affected part, continuously used twice daily
21 days.
Patient numbers：Every group each 80, M-F is close, and eczema, psoriasis, epifolliculitis, erythema Proportion of patients are identical.
Judgement of medicine curative effect standard：
Work well：Had clear improvement, or fully recovered after use using rear illing skin.
Effect is not notable：It is not improved using rear illing skin, or situation is aggravated.
Clinical trial statistical form
| Group | Work well/people | Effect not significantly/people | Work well percentage/% |
| Experimental group | 75 | 5 | 93.75 |
| Control group 1 | 52 | 28 | 65.00 |
| Control group 2 | 46 | 34 | 57.50 |
Experiment conclusion：
From experiment statisticses table data can with it is concluded that, the herbal composite medicament that experimental group is used has to skin disease
Preferable curative effect.The generation of allergic reaction or any adverse reaction is found no in experimental group, the medium-height grass is further demonstrated
The security of drug composition composition.
The patient of part control group 1 is after medicament is used for multiple times in the rear phenomenon for just observing part recovery from illness, the work of medicine
It is slow with speed.
The few patients of control group 2 generate of short duration red swelling of the skin, pruritis after using medicament, and in the short time
Interior symptom is died away.A portion patient, which occurs in that, uses the inapparent situation of rear effect.
Chinese herbal medicine combination medicament contained by the embodiment 1 that experimental group is used is helpful for treating for skin disease.Due to reality
Apply example 2,3,4,5,6 close with the formula composition of embodiment 1, other Example formulations also have close clinical effectiveness.
Contained drug preparation of the present invention can reach therapeutic effect by lotion, with various forms of externally applied formulations, contain
There are this treatment skin disease herbal composite and manufacture method all should be in the scope of the present invention.
The formula that the present invention is illustrated does not constitute the restriction to invention protection domain.Formula and manufacture method base more than
Improvement on plinth should be comprising within the scope of the present invention with replacement.
Claims (3)
1. one kind treats dermopathic herbal composite and its manufacture method, it is characterised in that former by following parts by weight
Material is made：3-5 parts of picria fel tarrae, 6-10 parts of pigeonpea, 6-10 parts of frutus cnidii, 2-5 parts of rose glorybower root, 10-15 parts of Celastrus angulatus, alangium
10-15 parts of leaf.
2. dermopathic Chinese herbal medicine combination is treated according to claim 1, it is characterised in that former including following parts by weight
Material：5 parts of picria fel tarrae, 10 parts of pigeonpea, 7 parts of frutus cnidii, 3 parts of rose glorybower root, 15 parts of Celastrus angulatus, 15 parts of Chinese alangium leaf.
3. dermopathic Chinese herbal medicine combination is treated according to claim 1, it is characterised in that the system of the herbal composite
Preparation Method is：The medicinal extract of total medicinal material content 8% is obtained after ethanol solution second extraction concentration Chinese herbal medicine, by 1kg fatty alcohol polyoxies
Vinethene, 1.5kg alkylglycosides, 0.5kg dodecyl benzyl dimethyl ammonium chlorides, 2kg OITs are dissolved in going for 10kg
In ionized water, the medicinal extract that 8kg is concentrated to give is added, mixture heating stirring 4hr is cooled to 20 DEG C of elimination insoluble matters and produced into
Product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710425583.6A CN107281328A (en) | 2017-06-02 | 2017-06-02 | One kind treats dermopathic herbal composite and its manufacture method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710425583.6A CN107281328A (en) | 2017-06-02 | 2017-06-02 | One kind treats dermopathic herbal composite and its manufacture method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107281328A true CN107281328A (en) | 2017-10-24 |
Family
ID=60096173
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710425583.6A Pending CN107281328A (en) | 2017-06-02 | 2017-06-02 | One kind treats dermopathic herbal composite and its manufacture method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107281328A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104474148A (en) * | 2015-01-16 | 2015-04-01 | 杜卫兵 | Traditional Chinese medicine composition used for treating dermatomycosis and preparation method thereof |
-
2017
- 2017-06-02 CN CN201710425583.6A patent/CN107281328A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104474148A (en) * | 2015-01-16 | 2015-04-01 | 杜卫兵 | Traditional Chinese medicine composition used for treating dermatomycosis and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 欧阳卫权: "《皮肤病中医外治特色疗法精选》", 31 October 2015, 广东科技出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102416023A (en) | Periplaneta Americana L. and gel externally applied medicinal composition and preparation method and use thereof in preparation of externally applied medicines for treating scalding | |
| CN104013878B (en) | A kind of lavipeditum medicine vinegar and preparation method thereof for treating tinea pedis | |
| CN104208153B (en) | One kind treats dermopathic Chinese medicine composition and its preparation | |
| CN1836715A (en) | External use medicine for quickly treating herpes zoster | |
| CN108498390A (en) | A kind of Tibetan book on Chinese herbal medicine extract and the preparation method and application thereof for treating acne | |
| CN106727925A (en) | Treat dermopathic Chinese medicinal ointment, preparation method and applications | |
| CN103845578B (en) | Treatment burn and scald, decubital ulcer, herpes zoster external-use tincture and preparation method | |
| CN103656092A (en) | Ointment for treating trauma and preparation method thereof | |
| CN114931611B (en) | A Chinese medicinal composition for treating burn, scald and wound, and its preparation method | |
| CN109700856A (en) | A kind of Chinese medicine external prescription relieved pain with promoting blood circulation and removing obstruction in channels, relaxing muscles and tendons | |
| CN105168286A (en) | Externally-applied medicine for treating herpes zoster | |
| CN107281328A (en) | One kind treats dermopathic herbal composite and its manufacture method | |
| CN105031170A (en) | Healthcare foot bath powder and preparing method thereof | |
| CN105233258A (en) | Composition for removing acne | |
| CN104815029B (en) | A kind of drug and preparation method thereof for treating tinea pedis | |
| CN103948726A (en) | Externally-applied traditional Chinese medicament for treating psoriasis and fungal infectious skin diseases and preparation thereof | |
| CN104490870A (en) | Compound topical cream and application thereof | |
| CN111700989B (en) | Traditional Chinese medicine composition for dispelling wind, eliminating dampness and treating tinea pedis and preparation method thereof | |
| CN102091209A (en) | Traditional Chinese medicine bath foam | |
| CN113384519A (en) | Formula and preparation method of chilblain cream | |
| CN106619238A (en) | Composition for treating chloasma | |
| CN107029086B (en) | Traditional Chinese medicine composition for treating dandruff | |
| WO2020197041A1 (en) | Injectable and cosmetic compositions comprising lemon balm extract as active ingredient | |
| CN104147366A (en) | External ointment for curing burns, scalds and carbuncles and preparing method thereof | |
| CN104800629B (en) | A kind of osteophyte-eliminating ointment and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20171024 |